chartexchange

GKOS
Glaukos Corporation
stockNYSE

At CloseNov 20, 2026 3:59:48 PM EST
237.18USD-0.388%(-0.92)1,084,347
After-hoursNov 20, 2026 4:10:30 PM EST
237.31USD+0.057%(+0.14)
203.87Bid269.89Ask66.02Spread
Loading…
Loading…
Healthcare
Medical Devices
CEO
Thomas Burns
HQ
Aliso Viejo, CA, USA
Previous Close
$238.10
Beta
1.01
52-Week High
$255.19 2026-11-04
52-Week Low
$93.78 2025-11-21
SMA 50
$189.55
SMA 200
$149.71
Avg. Vol 10D
863,784
Avg. Vol 30D
1.56M
Avg. Vol 90D
1.09M
Relative Vol
0.54
56.85M
0.2700%
GKOS Profile

glaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world's leading causes of blindness. glaukos has pioneered micro-invasive glaucoma surgery, or migs, to revolutionize the traditional glaucoma treatment and management paradigm. the company launched the istent trabecular micro-bypass stent, its first migs device, in the united states in 2012. glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. glaukos believes the istent is the smallest medical device ever approved by the food and drug administration, or fda, measuring 1.0 mm long and 0.33 mm wide. in june 2015, the company completed an initial public offering and its shares are now traded on the new york stock exchange unde

GKOS Performance
PeriodPriceDateChangeBeta
1W245.722026-11-13-3.43%-2.954
1M173.432026-10-20+36.83%1.891
3M184.892026-08-20+28.34%1.268
6M143.822026-05-20+64.99%0.659
1Y95.202025-11-20+149.26%1.013
2Y141.442024-11-20+67.77%—
5Y48.112021-11-19+393.23%1.171
GKOS Stock Summary

Glaukos Corporation (NYSE:GKOS) stock price today is $237.30, and today's volume is 846,667. GKOS is down 0.338% today. The 30 day average volume is 1.56M. GKOS market cap is $14.05B with 59.20M shares outstanding.